AzTrials
AzTrials

Cerebrovascular DisordersALVINANCT01146132

Nutrition and Physical Activity in Patients With Cerebrovascular Disease

A study testing Conventional diet +/- wine and Luxembourg variant of Mediterranean diet + physical activity +/- wine in people with Cerebrovascular Disorders, run by Manon Gantenbein at 1 site in Luxembourg.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The study will provide evidence of eating habits and physical activity in cerebrovascular patients in Luxembourg and of the degree to which these habits may be changed acutely (after one month) and in the long run (after 4 months) by intensive counselling. Read more about this study

Who is it for?
Ages 30 years and older
Conditions the study is for
Cerebrovascular Disorders
What is being tested?
Conventional diet +/- wine and Luxembourg variant of Mediterranean diet + physical activity +/- wine
Could I receive a placebo?
No, everyone receives an active treatment
How many people
119 participants
Where
1 siteLuxembourg
Study dates
Jun 2009to Dec 2011
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 30 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • In- and outpatients of the Neurology Department of the CHL and their family members
  • Carotid atherosclerosis assessed by B-mode ultrasound of at least 20% lumen reduction
  • No acute stroke/TIA/amaurosis fugax (at least 3 months ago)
  • Temporal ultrasound window suitable for recording of the middle cerebral artery
  • Ability to give informed consent

Who cannot join

  • No signed informed consent
  • patient not able to give informed consent

Trial locations and contacts

1 site in 1 country.

Luxembourg1 site
  • CHL

    Luxembourg, 1210

Other trials in Luxembourg

About this study

The study will provide evidence of eating habits and physical activity in cerebrovascular patients in Luxembourg and of the degree to which these habits may be changed acutely (after one month) and in the long run (after 4 months) by intensive counselling. Furthermore the influence of intensive counselling and of the consumption of red wine on cerebrovascular risk factors, cognition, and on surrogate parameters for stroke will be assessed.

Read the detailed description

Quality of life in the elderly and their families is severely affected by stroke and cognitive dysfunction caused by atherosclerosis of the brain supplying arteries. Nutrition, namely a Mediterranean-style diet, nuts, soybean products, whole grain products, dark chocolate, fish oil and avoidance of salt, and regular physical activity play a major role in the prevention of these diseases. Data are available on cardiac patients, however little is known on cerebrovascular patients. The role of red wine in the protection of cerebrovascular disease is discussed; it may be simply an epiphenomenon of otherwise healthy lifestyle in the population with a regularly low alcohol consumption not properly corrected for in epidemiological studies. No prospective randomised data is available.

We intend to perform a prospective randomised study on nutrition and physical activity in 100 patients with chronic cerebrovascular disease (i.e. patients with atherosclerotic stenosis, at least 20% of a brain supplying artery as demonstrated by carotid ultrasound and without an acute stroke/TIA). The study consists of three parts:

(1) Assessment of eating and physical activity habits in these patients and correlation with indicators of cerebrocardiovascular disease (cerebral perfusion as measured by transcranial Doppler sonography, pulsatility of the transcranial and extracranial Doppler signal, elasticity of the carotid artery, ankle-brachial index, cognitive functioning) and risk factors of cerebrovascular disease (blood pressure and blood pressure amplitude assessed by 24 h ambulatory blood pressure measurement; HDL, LDL, triglycerides, Lp(a), glucose, HbA1c, homocysteine, and fibrinogen; waist-hip ratio and BMI).

  1. Half of these patients will be randomised to intensive counselling concerning healthy eating and physical activity habits during the first month once a week. All the 100 patients will be reassessed after one month and after 4 months with the above mentioned parameters.
  2. In a double cross-over design half of the patients allocated to intensive counselling (i.e. n=25) and half of the patients without intensive counselling (n=25) will be allocated to 0,2 l of red wine daily (men) or 0,1l of red wine daily (women), respectively. The remaining 50 patients will be advised to avoid red wine for the time of the study.
Being tested
Conventional diet +/- wine, Luxembourg variant of Mediterranean diet + physical activity +/- wine
Keywords
Nutrition, Physical activity, Cerebrovascular disease, wine consumption, BMI, Pulse transit time, transcranial Doppler sonography
Medical subject headings
Cerebrovascular Disorders, Motor Activity

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional diet +/- wineDietary supplement

    usual eating habits

  • Luxembourg variant of Mediterranean diet + physical activity +/- wineDietary supplement

    Walnuts, almonds, mustard and soy bean products as part of the Indo-Mediterranean diet could be recommended to ensure a variety of food constellation, as well as dark chocolate. This form of diet will be addressed to as "Luxembourg variant of the Mediterranean diet"

Study groups in NCT01146132
Study groupRoleWhat they receive
Luxembourg diet + wineOtherLuxembourg variant of the mediterranean Diet, physical activity with wine consumption
Receives: Dietary Supplement: Luxembourg variant of Mediterranean diet + physical activity +/- wine
conventional + wineOtherconventional Diet with red wine
Receives: Dietary Supplement: Conventional diet +/- wine
conventionalOtherconventional diet without wine
Receives: Dietary Supplement: Conventional diet +/- wine
Luxembourg dietOtherLuxembourg variant of the mediterranean Diet, physical activity with wine consumption
Receives: Dietary Supplement: Luxembourg variant of Mediterranean diet + physical activity +/- wine

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Differences in mean systolic blood pressure in the two diet/sport arms

    Assess the influence of intensive counselling and of the consumption of red wine on cerebrovascular risk factors, cognition and on surrogate parameters for cerebrovascular disease.

    Measured: 4 months

Secondary outcomes (2)
  1. Effects on cerebrovascular health profile

    Assess effects on cerebrocardiovascular health profile, cognitive function and ultrasound parameters.

    Measured: 4 months

  2. Assessment of genetic marker and/or genetic modifications.

    The genetic analyses will investigate:

    1. Profiles of inflammatory, anti-inflammatory cytokines B) Genes related to risk of stroke C) Chromosome regions related to atherosclerosis D) Genetic polymorphism in inflammation

    Genes to be analyzed: FABP2, MTP1, ApoE, ApoA1, PPAR gamma Pro 12 Ala, TNF alpha, Paraoxonase 1, ADH, Kinesin-like protein (KIF) 6 Trp719Arg (rs20455), SNP, 5 (component of complement 5) 2416A> G variant (rs17611), sCAMs (sICAM-1, sVCAM-1, sPSEL et sESEL), (C3, C4) Complement and CRP, P-selectin and its ligand, P-selectin glycoprotein ligand 1

    Measured: Baseline

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Jun 2010 (estimated)
  2. Study startJun 2009
  3. Primary completionDec 2011
  4. Study completionDec 2011

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Investigator
Enrolment
119 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01146132
Sponsor's protocol ID
CRP-Santé
Acronym
ALVINA
Status last verified
Oct 2012
First submitted
15 Jun 2010
Last updated
5 Oct 2012
Results posted
No
Data monitoring committee
No

Publications

  • Droste DW, Iliescu C, Vaillant M, Gantenbein M, De Bremaeker N, Lieunard C, Velez T, Meyer M, Guth T, Kuemmerle A, Gilson G, Chioti A. A daily glass of red wine associated with lifestyle changes independently improves blood lipids in patients with carotid arteriosclerosis: results from a randomized controlled trial. Nutr J. 2013 Nov 15;12(1):147. doi: 10.1186/1475-2891-12-147.

    PubMed 24228901

Questions about this trial

What is this clinical trial studying?

A study testing Conventional diet +/- wine and Luxembourg variant of Mediterranean diet + physical activity +/- wine in people with Cerebrovascular Disorders, run by Manon Gantenbein at 1 site in Luxembourg.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 5 Oct 2012. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Luxembourg. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Differences in mean systolic blood pressure in the two diet/sport arms (time frame: 4 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT01146132, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 Oct 2012.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in